Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
Galera Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Galera Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at Galera Therapeutics received on average a compensation package of $1.7M, a 23% decrease compared to previous year.
Average pay of disclosed executives at Galera Therapeutics
J. Mel Sorensen, Chief Executive Officer, received $2.5M in total, which decreased by 14% compared to 2020. 68% of Sorensen's compensation, or $1.7M, was in option awards. Sorensen also received $241K in non-equity incentive plan, $568K in salary, as well as $12K in other compensation.
Mark Bachleda, Chief Commercial Officer, received a compensation package of $1.3M. 89% of the compensation package, or $1.1M, was in option awards.
Christopher Degnan, Chief Financial Officer, earned $1.3M in 2021, a 13% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.